134 related articles for article (PubMed ID: 7623729)
21. The comparison of outcome and cost of three protocols for childhood non-high risk acute lymphoblastic leukemia in China.
Luo XQ; Ke ZY; Guan XQ; Zhang YC; Huang LB; Zhu J
Pediatr Blood Cancer; 2008 Aug; 51(2):204-9. PubMed ID: 18454471
[TBL] [Abstract][Full Text] [Related]
22. The treatment of childhood acute lymphoblastic leukemia in Guatemala: Biologic features, treatment hurdles, and results.
Antillón FG; Blanco JG; Valverde PD; Castellanos M; Garrido CP; Girón V; Letona TR; Osorio EJ; Borrayo DA; Mack RA; Melgar MA; Lorenzana R; Ribeiro RC; Metzger M; Conter V; Rossi E; Valsecchi MG
Cancer; 2017 Feb; 123(3):436-448. PubMed ID: 27683100
[TBL] [Abstract][Full Text] [Related]
23. Economic evaluation of treatment for acute lymphoblastic leukaemia in childhood.
Rae C; Furlong W; Jankovic M; Moghrabi A; Naqvi A; Sala A; Samson Y; DePauw S; Feeny D; Barr R
Eur J Cancer Care (Engl); 2014 Nov; 23(6):779-85. PubMed ID: 24393150
[TBL] [Abstract][Full Text] [Related]
24. Treatment and prognosis of childhood acute lymphoblastic leukemia on protocols ALL-BFM 90, 95 and ALL IC-BFM 2002: a retrospective single-center study from Olomouc, Czech Republic.
Volejnikova J; Jarosova M; Pospisilova D; Novak Z; Vrbkova J; Hajduch M; Mihal V
Neoplasma; 2016; 63(3):456-61. PubMed ID: 26925793
[TBL] [Abstract][Full Text] [Related]
25. Clinical outcome, healthcare cost and length of hospital stay among patients with bloodstream infections and acute leukemia in a cancer center in eastern india.
Muennichow CE; Goel G; Bhattacharyya A; Nair R; Chandy M; Bhattacharya S
Infect Control Hosp Epidemiol; 2018 Aug; 39(8):1013-1014. PubMed ID: 29909820
[No Abstract] [Full Text] [Related]
26. International collaboration on childhood leukemia.
Pui CH; Ribeiro RC
Int J Hematol; 2003 Dec; 78(5):383-9. PubMed ID: 14704030
[TBL] [Abstract][Full Text] [Related]
27. A cost comparison of laboratory charges in treating childhood leukemia. A children's cancer group analysis.
Baranko PV
Am J Pediatr Hematol Oncol; 1994 May; 16(2):102-3. PubMed ID: 8166361
[TBL] [Abstract][Full Text] [Related]
28. Intensive chemotherapy for childhood acute lymphoblastic leukemia: results of the randomized intercontinental trial ALL IC-BFM 2002.
Stary J; Zimmermann M; Campbell M; Castillo L; Dibar E; Donska S; Gonzalez A; Izraeli S; Janic D; Jazbec J; Konja J; Kaiserova E; Kowalczyk J; Kovacs G; Li CK; Magyarosy E; Popa A; Stark B; Jabali Y; Trka J; Hrusak O; Riehm H; Masera G; Schrappe M
J Clin Oncol; 2014 Jan; 32(3):174-84. PubMed ID: 24344215
[TBL] [Abstract][Full Text] [Related]
29. Time trend in frequency of occurrence of major immunophenotypes in paediatric acute lymphoblastic leukemia cases as experienced by Cancer Institute, Chennai, south India during the period 1989-2009.
Rajalekshmy KR; Abitha AR; Anuratha N; Sagar TG
Indian J Cancer; 2011; 48(3):310-5. PubMed ID: 21921330
[TBL] [Abstract][Full Text] [Related]
30. Association of Macroeconomic Factors With Nonrelapse Mortality After Allogeneic Hematopoietic Cell Transplantation for Adults With Acute Lymphoblastic Leukemia: An Analysis From the Acute Leukemia Working Party of the EBMT.
Giebel S; Labopin M; Ibatici A; Browne P; Czerw T; Socie G; Unal A; Kyrcz-Krzemien S; Bacigalupo A; Goker H; Potter M; Furness CL; McQuaker G; Beelen D; Milpied N; Campos A; Craddock C; Nagler A; Mohty M
Oncologist; 2016 Mar; 21(3):377-83. PubMed ID: 26869584
[TBL] [Abstract][Full Text] [Related]
31. Survival of childhood acute lymphoblastic leukemia: experience in Chennai.
Rajajee S; Desikulu MV; Pushpa V
J Trop Pediatr; 1999 Dec; 45(6):367-70. PubMed ID: 10667009
[TBL] [Abstract][Full Text] [Related]
32. Second relapse in childhood acute lymphoblastic leukemia: a call for action.
Kulkarni KP; Marwaha RK
Indian J Pediatr; 2011 Mar; 78(3):362-3. PubMed ID: 21046288
[No Abstract] [Full Text] [Related]
33. Outcome of childhood acute lymphoblastic leukemia in Jordan.
Halalsheh H; Abuirmeileh N; Rihani R; Bazzeh F; Zaru L; Madanat F
Pediatr Blood Cancer; 2011 Sep; 57(3):385-91. PubMed ID: 21360658
[TBL] [Abstract][Full Text] [Related]
34. Significant male preponderance in childhood acute lymphoblastic leukemia in India and regional variation: tertiary care center experience, systematic review, and evaluation of population-based data.
Kulkarni KP; Marwaha RK
Pediatr Hematol Oncol; 2013 Sep; 30(6):557-67. PubMed ID: 23528149
[TBL] [Abstract][Full Text] [Related]
35. Cost-effectiveness of treatment of childhood acute lymphoblastic leukemia with chemotherapy only: the influence of new medication and diagnostic technology.
van Litsenburg RR; Uyl-de Groot CA; Raat H; Kaspers GJ; Gemke RJ
Pediatr Blood Cancer; 2011 Dec; 57(6):1005-10. PubMed ID: 21618420
[TBL] [Abstract][Full Text] [Related]
36. Fixed price contracts: the case of pediatric acute lymphoblastic leukemia.
Durand-Zaleski I
Health Policy; 1992 May; 21(1):65-76. PubMed ID: 10119195
[TBL] [Abstract][Full Text] [Related]
37. Seasonality in diagnosis of childhood acute lymphoblastic leukemia: impact on disease presentation, survival outcome and resources.
Kulkarni KP; Marwaha RK
J Pediatr Hematol Oncol; 2013 Jan; 35(1):81-2. PubMed ID: 23242329
[No Abstract] [Full Text] [Related]
38. Acute lymphoblastic leukemia in low and middle-income countries: disease characteristics and treatment results.
Abboud MR; Ghanem K; Muwakkit S
Curr Opin Oncol; 2014 Nov; 26(6):650-5. PubMed ID: 25202926
[TBL] [Abstract][Full Text] [Related]
39. Immunophenotyping of acute lymphoblastic leukaemia in Madras, India.
Rajalekshmy KR; Abitha AR; Pramila R; Gnanasagar T; Maitreyan V; Shanta V
Leuk Res; 1994 Mar; 18(3):183-90. PubMed ID: 8139286
[TBL] [Abstract][Full Text] [Related]
40. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
Burkhardt B; Reiter A; Landmann E; Lang P; Lassay L; Dickerhoff R; Lakomek M; Henze G; von Stackelberg A
J Clin Oncol; 2009 Jul; 27(20):3363-9. PubMed ID: 19433688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
